Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals

Identifieur interne : 002C15 ( Main/Exploration ); précédent : 002C14; suivant : 002C16

Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals

Auteurs : Junbao Yang [États-Unis] ; Eddie James [États-Unis] ; Michelle Roti [États-Unis] ; Laurie Huston [États-Unis] ; John A. Gebe [États-Unis] ; William W. Kwok [États-Unis]

Source :

RBID : ISTEX:7A829C7ABFA12E0A0EFA5E81E87A85C9C7F396E7

Descripteurs français

English descriptors

Abstract

Identification of dominant T cell epitopes within newly emerging and re-emerging infectious organisms is valuable in understanding pathogenic immune responses and potential vaccine designs. However, difficulties in obtaining samples from patients or convalescent subjects have hampered research in this direction. We demonstrated a strategy, tetramer-guided epitope mapping, that specific CD4+ T cell epitopes can be identified by using PBMC from subjects that have not been exposed to the infectious organism. Sixteen HLA-DR0401- and 14 HLA-DR0701-restricted epitopes within spike protein of severe acute respiratory syndrome-coronavirus (SARS-CoV) were identified. Among these, spike protein residues 159–171, 166–178, 449–461 and 1083–1097 were identified to contain naturally processed immunodominant epitopes based on strong in vitro T cell responses of PBMC (as assayed by tetramer staining) to intact spike protein stimulation. These immunodominant epitopes were confirmed in vivo in HLA-DR0401 transgenic mice by immunizing with spike protein. Furthermore, the epitope-specific T cells from naive donors secreted IFN-γ and IL-13 upon re-stimulation with corresponding tetramers. Our study demonstrates a strategy to determine potential immunodominant epitopes for emerging infectious pathogens prior to their epidemic circulation.

Url:
DOI: 10.1093/intimm/dxn124


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals</title>
<author>
<name sortKey="Yang, Junbao" sort="Yang, Junbao" uniqKey="Yang J" first="Junbao" last="Yang">Junbao Yang</name>
</author>
<author>
<name sortKey="James, Eddie" sort="James, Eddie" uniqKey="James E" first="Eddie" last="James">Eddie James</name>
</author>
<author>
<name sortKey="Roti, Michelle" sort="Roti, Michelle" uniqKey="Roti M" first="Michelle" last="Roti">Michelle Roti</name>
</author>
<author>
<name sortKey="Huston, Laurie" sort="Huston, Laurie" uniqKey="Huston L" first="Laurie" last="Huston">Laurie Huston</name>
</author>
<author>
<name sortKey="Gebe, John A" sort="Gebe, John A" uniqKey="Gebe J" first="John A." last="Gebe">John A. Gebe</name>
</author>
<author>
<name sortKey="Kwok, William W" sort="Kwok, William W" uniqKey="Kwok W" first="William W." last="Kwok">William W. Kwok</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:7A829C7ABFA12E0A0EFA5E81E87A85C9C7F396E7</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1093/intimm/dxn124</idno>
<idno type="url">https://api.istex.fr/ark:/67375/HXZ-RCRGKT04-R/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000521</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000521</idno>
<idno type="wicri:Area/Istex/Curation">000521</idno>
<idno type="wicri:Area/Istex/Checkpoint">000B78</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000B78</idno>
<idno type="wicri:doubleKey">0953-8178:2009:Yang J:searching:immunodominant:epitopes</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2638843</idno>
<idno type="RBID">PMC:2638843</idno>
<idno type="wicri:Area/Pmc/Corpus">001064</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001064</idno>
<idno type="wicri:Area/Pmc/Curation">001064</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001064</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000D84</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000D84</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:19050106</idno>
<idno type="wicri:Area/PubMed/Corpus">001A21</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001A21</idno>
<idno type="wicri:Area/PubMed/Curation">001A21</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001A21</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001792</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001792</idno>
<idno type="wicri:Area/Ncbi/Merge">001D98</idno>
<idno type="wicri:Area/Ncbi/Curation">001D98</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001D98</idno>
<idno type="wicri:doubleKey">0953-8178:2008:Yang J:searching:immunodominant:epitopes</idno>
<idno type="wicri:Area/Main/Merge">002C69</idno>
<idno type="wicri:Area/Main/Curation">002C15</idno>
<idno type="wicri:Area/Main/Exploration">002C15</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals</title>
<author>
<name sortKey="Yang, Junbao" sort="Yang, Junbao" uniqKey="Yang J" first="Junbao" last="Yang">Junbao Yang</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Benaroya Research Institute at Virginia Mason, Seattle, WA</wicri:regionArea>
<placeName>
<region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="James, Eddie" sort="James, Eddie" uniqKey="James E" first="Eddie" last="James">Eddie James</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Benaroya Research Institute at Virginia Mason, Seattle, WA</wicri:regionArea>
<placeName>
<region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Roti, Michelle" sort="Roti, Michelle" uniqKey="Roti M" first="Michelle" last="Roti">Michelle Roti</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Benaroya Research Institute at Virginia Mason, Seattle, WA</wicri:regionArea>
<placeName>
<region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Huston, Laurie" sort="Huston, Laurie" uniqKey="Huston L" first="Laurie" last="Huston">Laurie Huston</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Benaroya Research Institute at Virginia Mason, Seattle, WA</wicri:regionArea>
<placeName>
<region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gebe, John A" sort="Gebe, John A" uniqKey="Gebe J" first="John A." last="Gebe">John A. Gebe</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Benaroya Research Institute at Virginia Mason, Seattle, WA</wicri:regionArea>
<placeName>
<region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kwok, William W" sort="Kwok, William W" uniqKey="Kwok W" first="William W." last="Kwok">William W. Kwok</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Benaroya Research Institute at Virginia Mason, Seattle, WA</wicri:regionArea>
<placeName>
<region type="state">Washington (État)</region>
</placeName>
</affiliation>
<affiliation wicri:level="4">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Immunology, University of Washington, Seattle, WA</wicri:regionArea>
<placeName>
<region type="state">Washington (État)</region>
<settlement type="city">Seattle</settlement>
</placeName>
<orgName type="university">Université de Washington</orgName>
</affiliation>
<affiliation></affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">International Immunology</title>
<idno type="eISSN">1460-2377</idno>
<idno type="ISSN">0953-8178</idno>
<imprint>
<publisher>Oxford University Press</publisher>
<date>2009</date>
<date type="e-published">2008</date>
<biblScope unit="vol">21</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="63">63</biblScope>
<biblScope unit="page" to="71">71</biblScope>
</imprint>
<idno type="ISSN">0953-8178</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0953-8178</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Animals</term>
<term>CD4-Positive T-Lymphocytes (immunology)</term>
<term>CD4-Positive T-Lymphocytes (metabolism)</term>
<term>CD4-Positive T-Lymphocytes (virology)</term>
<term>Cell Proliferation</term>
<term>Cytokines (biosynthesis)</term>
<term>Cytokines (immunology)</term>
<term>Epitope Mapping</term>
<term>Histocompatibility Antigens Class II (immunology)</term>
<term>Histocompatibility Antigens Class II (metabolism)</term>
<term>Humans</term>
<term>Immunodominant Epitopes (immunology)</term>
<term>Immunodominant Epitopes (metabolism)</term>
<term>Membrane Glycoproteins (immunology)</term>
<term>Membrane Glycoproteins (metabolism)</term>
<term>Mice</term>
<term>Mice, Transgenic</term>
<term>Molecular Sequence Data</term>
<term>SARS Virus (immunology)</term>
<term>SARS Virus (metabolism)</term>
<term>Severe Acute Respiratory Syndrome (epidemiology)</term>
<term>Severe Acute Respiratory Syndrome (immunology)</term>
<term>Severe Acute Respiratory Syndrome (virology)</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Viral Envelope Proteins (immunology)</term>
<term>Viral Envelope Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Antigènes d'histocompatibilité de classe II (immunologie)</term>
<term>Antigènes d'histocompatibilité de classe II (métabolisme)</term>
<term>Cartographie épitopique</term>
<term>Cytokines (biosynthèse)</term>
<term>Cytokines (immunologie)</term>
<term>Données de séquences moléculaires</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycoprotéines membranaires (immunologie)</term>
<term>Glycoprotéines membranaires (métabolisme)</term>
<term>Humains</term>
<term>Lymphocytes T CD4+ (immunologie)</term>
<term>Lymphocytes T CD4+ (métabolisme)</term>
<term>Lymphocytes T CD4+ (virologie)</term>
<term>Prolifération cellulaire</term>
<term>Protéines de l'enveloppe virale (immunologie)</term>
<term>Protéines de l'enveloppe virale (métabolisme)</term>
<term>Souris</term>
<term>Souris transgéniques</term>
<term>Syndrome respiratoire aigu sévère (immunologie)</term>
<term>Syndrome respiratoire aigu sévère (virologie)</term>
<term>Syndrome respiratoire aigu sévère (épidémiologie)</term>
<term>Séquence d'acides aminés</term>
<term>Virus du SRAS (immunologie)</term>
<term>Virus du SRAS (métabolisme)</term>
<term>Épitopes immunodominants (immunologie)</term>
<term>Épitopes immunodominants (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en">
<term>Cytokines</term>
</keywords>
<keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr">
<term>Cytokines</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Antigènes d'histocompatibilité de classe II</term>
<term>Cytokines</term>
<term>Glycoprotéines membranaires</term>
<term>Lymphocytes T CD4+</term>
<term>Protéines de l'enveloppe virale</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Virus du SRAS</term>
<term>Épitopes immunodominants</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>CD4-Positive T-Lymphocytes</term>
<term>Cytokines</term>
<term>Histocompatibility Antigens Class II</term>
<term>Immunodominant Epitopes</term>
<term>Membrane Glycoproteins</term>
<term>SARS Virus</term>
<term>Severe Acute Respiratory Syndrome</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>CD4-Positive T-Lymphocytes</term>
<term>Histocompatibility Antigens Class II</term>
<term>Immunodominant Epitopes</term>
<term>Membrane Glycoproteins</term>
<term>SARS Virus</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Antigènes d'histocompatibilité de classe II</term>
<term>Glycoprotéines membranaires</term>
<term>Lymphocytes T CD4+</term>
<term>Protéines de l'enveloppe virale</term>
<term>Virus du SRAS</term>
<term>Épitopes immunodominants</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Lymphocytes T CD4+</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>CD4-Positive T-Lymphocytes</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Cell Proliferation</term>
<term>Epitope Mapping</term>
<term>Humans</term>
<term>Mice</term>
<term>Mice, Transgenic</term>
<term>Molecular Sequence Data</term>
<term>Spike Glycoprotein, Coronavirus</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Cartographie épitopique</term>
<term>Données de séquences moléculaires</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Humains</term>
<term>Prolifération cellulaire</term>
<term>Souris</term>
<term>Souris transgéniques</term>
<term>Séquence d'acides aminés</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Identification of dominant T cell epitopes within newly emerging and re-emerging infectious organisms is valuable in understanding pathogenic immune responses and potential vaccine designs. However, difficulties in obtaining samples from patients or convalescent subjects have hampered research in this direction. We demonstrated a strategy, tetramer-guided epitope mapping, that specific CD4+ T cell epitopes can be identified by using PBMC from subjects that have not been exposed to the infectious organism. Sixteen HLA-DR0401- and 14 HLA-DR0701-restricted epitopes within spike protein of severe acute respiratory syndrome-coronavirus (SARS-CoV) were identified. Among these, spike protein residues 159–171, 166–178, 449–461 and 1083–1097 were identified to contain naturally processed immunodominant epitopes based on strong in vitro T cell responses of PBMC (as assayed by tetramer staining) to intact spike protein stimulation. These immunodominant epitopes were confirmed in vivo in HLA-DR0401 transgenic mice by immunizing with spike protein. Furthermore, the epitope-specific T cells from naive donors secreted IFN-γ and IL-13 upon re-stimulation with corresponding tetramers. Our study demonstrates a strategy to determine potential immunodominant epitopes for emerging infectious pathogens prior to their epidemic circulation.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Washington (État)</li>
</region>
<settlement>
<li>Seattle</li>
</settlement>
<orgName>
<li>Université de Washington</li>
</orgName>
</list>
<tree>
<country name="États-Unis">
<region name="Washington (État)">
<name sortKey="Yang, Junbao" sort="Yang, Junbao" uniqKey="Yang J" first="Junbao" last="Yang">Junbao Yang</name>
</region>
<name sortKey="Gebe, John A" sort="Gebe, John A" uniqKey="Gebe J" first="John A." last="Gebe">John A. Gebe</name>
<name sortKey="Huston, Laurie" sort="Huston, Laurie" uniqKey="Huston L" first="Laurie" last="Huston">Laurie Huston</name>
<name sortKey="James, Eddie" sort="James, Eddie" uniqKey="James E" first="Eddie" last="James">Eddie James</name>
<name sortKey="Kwok, William W" sort="Kwok, William W" uniqKey="Kwok W" first="William W." last="Kwok">William W. Kwok</name>
<name sortKey="Kwok, William W" sort="Kwok, William W" uniqKey="Kwok W" first="William W." last="Kwok">William W. Kwok</name>
<name sortKey="Roti, Michelle" sort="Roti, Michelle" uniqKey="Roti M" first="Michelle" last="Roti">Michelle Roti</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C15 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002C15 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:7A829C7ABFA12E0A0EFA5E81E87A85C9C7F396E7
   |texte=   Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021